These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6382320)

  • 21. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.
    Vilkin A; Rozen P; Levi Z; Waked A; Maoz E; Birkenfeld S; Niv Y
    Am J Gastroenterol; 2005 Nov; 100(11):2519-25. PubMed ID: 16279909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colon and rectal cancer: etiology and screening.
    Sherlock P; Winawer SJ
    Compr Ther; 1981 Dec; 7(12):28-35. PubMed ID: 7318402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of immunologic markers in the diagnosis and monitoring of large-intestinal neoplasms].
    Harłozińska-Szmyrka A
    Pol Arch Med Wewn; 1992; 88(2-3):181-9. PubMed ID: 1492024
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical significance of plasma CEA assay in the patients with colorectal carcinoma.
    Tamura T; Kunitomo K; Korematsu H; Ando M; Fujita H; Iwasaka N; Yoshikawa H; Kuwashima T; Komi N
    Tokushima J Exp Med; 1982 Jun; 29(1-2):71-6. PubMed ID: 7147244
    [No Abstract]   [Full Text] [Related]  

  • 25. [Blood in feces. A screening method for early discovery of colorectal cancer].
    Kewenter J
    Lakartidningen; 1994 Mar; 91(9):803-4. PubMed ID: 8139343
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunohistochemical study of ovarian tumors using the OC 125 monoclonal antibody as a basis for potential in vivo and in vitro applications.
    Mainguené C; Aillet G; Kremer M; Chatal JF
    J Nucl Med Allied Sci; 1986; 30(1):19-22. PubMed ID: 3528419
    [No Abstract]   [Full Text] [Related]  

  • 27. An adapted program of colorectal cancer screening--7 years experience and cost-benefit analysis.
    Fric P; Zavoral M; Dvoráková H; Zoubek V; Roth Z
    Hepatogastroenterology; 1994 Oct; 41(5):413-6. PubMed ID: 7851847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mass screening for early discovery of colorectal cancer--are we ready].
    Brevinge H
    Lakartidningen; 2000 Sep; 97(36):3916-8. PubMed ID: 11036346
    [No Abstract]   [Full Text] [Related]  

  • 29. Colon cancer screening. Sigmoidoscopy or colonoscopy.
    Khullar SK; DiSario JA
    Gastrointest Endosc Clin N Am; 1997 Jul; 7(3):365-86. PubMed ID: 9177140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An applied study on the method of multi-factorial quantitative-risk assessment (MFQRA) for mass screening of colorectal cancer].
    Chen K
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):37-40. PubMed ID: 8334938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for colorectal cancer.
    Diehl AK
    J Fam Pract; 1981 Apr; 12(4):625-32. PubMed ID: 7205165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for rectal cancer: will it improve cure rates?
    Tweedle EM; Rooney PS; Watson AJ
    Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):639-48. PubMed ID: 17764916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of CEA and CA242 in the diagnosis of colorectal carcinoma].
    Wu J; Yu H; Shao Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):438-40. PubMed ID: 8697997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The detection of colorectal carcinomas with the use of CA-50 radioimmunoassay inhibition test.
    Habib NA; Hershman MJ; Papp L; Swift I; Williamson RC; Wood CB
    Int J Colorectal Dis; 1986 Jul; 1(3):186-7. PubMed ID: 3475393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Screening for colorectal neoplasms. A review and recommendations].
    Kronborg O
    Ugeskr Laeger; 1993 Oct; 155(41):3272-7. PubMed ID: 8256320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Colorectal neoplasms: preoperative determination of GICA].
    Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
    Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
    [No Abstract]   [Full Text] [Related]  

  • 38. [The French National Society of Gastroenterology recommends systematic organized screening for colorectal cancer in France].
    Bretagne JF; Faivre J
    Gastroenterol Clin Biol; 2000 May; 24(5):492-3. PubMed ID: 10891735
    [No Abstract]   [Full Text] [Related]  

  • 39. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer.
    Anthony T; Simmang C; Hyman N; Buie D; Kim D; Cataldo P; Orsay C; Church J; Otchy D; Cohen J; Perry WB; Dunn G; Rafferty J; Ellis CN; Rakinic J; Fleshner P; Stahl T; Gregorcyk S; Ternent C; Kilkenny JW; Whiteford M;
    Dis Colon Rectum; 2004 Jun; 47(6):807-17. PubMed ID: 15108028
    [No Abstract]   [Full Text] [Related]  

  • 40. Endoscopy in asymptomatics previously submitted to anterior resection for colorectal cancer.
    Aste H; Pugliese V; Nicolò G; Santi L
    Cancer Detect Prev; 1981; 4(1-4):417-20. PubMed ID: 7349804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.